What Medrobotics does

Medrobotics is a privately held medical robotics company founded in 2005 and headquartered in Raynham, Massachusetts, that develops and commercializes the Flex Robotic System. The company serves hospitals and specialty clinics performing flexible endoscopic surgery, including gastrointestinal, colorectal, and oral procedures, where the Flex platform is positioned to address demand for minimally invasive surgery and improved access to anatomical regions with flexible instruments. Medrobotics is referenced alongside Intuitive Surgical, Medtronic, Stryker, and CMR Surgical as a key player in the broader surgical robotics market, and it holds an estimated 34.9% share of the oral surgery robot segment.

The Flex Robotic System is described as a semi-autonomous platform for flexible endoscopic surgery robots, differentiating Medrobotics through its flexible-scope architecture rather than the rigid laparoscopic approach used by incumbent general surgery robotics systems. Detailed technical specifications, patent counts, and product architecture are not disclosed in the available source material, and no AI/ML capabilities, named models, or data assets are documented. The company operates with 101-250 employees and serves customers in North America, with no documented international commercial presence.

Medrobotics operates a capital equipment business model typical of surgical robotics, selling or placing robotic systems with healthcare providers rather than pursuing a recurring software or consumables-only revenue model. Pricing and distribution channels are not publicly disclosed. Across 14 funding rounds between 2009 and 2018, the company raised approximately $206 million from investors including Western Technology Investment, Hercules Capital, Eagle Ventures, Pittsburgh Life Sciences Greenhouse, and Slater Technology Fund. The last disclosed financing was a $25 million round led by Western Technology Investment in June 2018, and no subsequent funding activity, product launches, partnerships, or acquisitions are documented in the available data.

Name

Medrobotics

Website

https://medrobotics.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Raynham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Core offering

Medrobotics develops and commercializes the Flex Robotic System, a robotic-assisted surgical platform designed for flexible endoscopic and minimally invasive procedures. The system is targeted at hospitals and specialty clinics performing gastrointestinal, colorectal, transoral, and other natural orifice surgeries that are difficult to access with rigid laparoscopic or conventional endoscopic tools.

Product overview

Medrobotics is a surgical robotics company operating in the broader surgical robotics and robotic endoscopy device markets. The company is mentioned as a key player in the oral surgery robot market, the robotic endoscopy device market, and the U.S. Flexible Endoscopic Surgery Robot Market. However, no specific product names, detailed product descriptions, or product architecture information were available in the provided source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Flex Robotic System Robotic-assisted surgical platform for flexible endoscopic and minimally invasive procedures, including gastrointestinal, colorectal, transoral, and other natural orifice surgeries. Targeted at hospitals and specialty clinics seeking to access anatomically challenging sites with greater precision than rigid laparoscopic tools allow.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Emerging players

• Asensus Surgical: Asensus Surgical develops the Senhance robotic surgical platform for laparoscopic procedures, making it an emerging peer in the same surgical robotics category as Medrobotics. Both are smaller, publicly-traded challengers to Intuitive Surgical.
• Moon Surgical: Moon Surgical is developing a collaborative surgical robotics platform for laparoscopic procedures. As an emerging player, it represents a newer entrant competing in the same broader surgical robotics category where Medrobotics operates.
• Vicarious Surgical: Vicarious Surgical is developing a virtual-reality-enabled surgical robotics system. As an emerging player, it shares Medrobotics' positioning as a smaller, technology-focused challenger in surgical robotics with a differentiated platform approach.
• THINK Surgical: THINK Surgical develops robotic systems for orthopedic surgery, particularly knee procedures. While focused on orthopedics rather than flexible endoscopy, it is comparable as a smaller, specialized surgical robotics platform developer competing against larger incumbents.
• Renishaw: Renishaw has developed neurosurgical robotic platforms (Neuromate) and entered the broader surgical robotics market. As a precision engineering company extending into surgical robotics, it is a comparable peer in developing specialized robotic surgical systems for defined clinical niches.

Direct peers

• Medtronic: Medtronic's Hugo robotic-assisted surgery platform places it as a direct peer, mentioned alongside Medrobotics in the surgical robotics market. Both target minimally invasive procedures, though Medtronic competes more broadly across specialties while Medrobotics focuses on flexible endoscopy.
• Intuitive Surgical: Intuitive Surgical is the dominant player in surgical robotics with the da Vinci platform and is explicitly cited alongside Medrobotics in market reports. Both companies develop robotic-assisted minimally invasive surgical systems, though Intuitive focuses on rigid laparoscopic platforms while Medrobotics specializes in flexible endoscopy.
• CMR Surgical: CMR Surgical's Versius system is a direct surgical robotics peer, explicitly named in the same market reports as Medrobotics. Both companies develop compact robotic platforms for minimally invasive surgery, competing for hospital capital equipment budgets.

Broad incumbents

• Stryker: Stryker operates the Mako robotic platform primarily for orthopedic surgery and is mentioned alongside Medrobotics in surgical robotics market reports. As a broad incumbent medical device company, Stryker has substantially more capital, distribution, and installed base than Medrobotics.
• Johnson & Johnson (Johnson & Johnson MedTech): Johnson & Johnson is developing the Ottava robotic surgery platform and is cited as a key competitor in the surgical robotics market. As a broad incumbent with massive R&D resources, J&J represents both a competitive threat and a potential strategic acquirer of Medrobotics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medrobotics
• LinkedInlinkedin.com/company/medrobotics-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds14 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medrobotics